688399 硕世生物
已收盘 12-17 15:00:01
资讯
新帖
简况
硕世生物最新公告:公司猴痘病毒核酸检测试剂盒被列入WHO应急使用清单
证券之星 · 12-07
硕世生物最新公告:公司猴痘病毒核酸检测试剂盒被列入WHO应急使用清单
硕世生物(688399)披露实际控制人续签一致行动协议,12月05日股价下跌0.77%
证券之星 · 12-05
硕世生物(688399)披露实际控制人续签一致行动协议,12月05日股价下跌0.77%
硕世生物(688399)11月20日股东户数0.77万户,较上期增加2.64%
证券之星 · 12-03
硕世生物(688399)11月20日股东户数0.77万户,较上期增加2.64%
硕世生物:截至2025年11月10日,公司股东总数7512户
证券日报 · 11-18
硕世生物:截至2025年11月10日,公司股东总数7512户
每周股票复盘:硕世生物(688399)召开2025年第二次临时股东大会并通过多项治理议案
证券之星 · 11-16
每周股票复盘:硕世生物(688399)召开2025年第二次临时股东大会并通过多项治理议案
硕世生物(688399)披露2025年第二次临时股东大会决议公告,11月11日股价下跌1.65%
证券之星 · 11-11
硕世生物(688399)披露2025年第二次临时股东大会决议公告,11月11日股价下跌1.65%
每周股票复盘:硕世生物(688399)拟取消监事会并调整注册资本
证券之星 · 11-02
每周股票复盘:硕世生物(688399)拟取消监事会并调整注册资本
硕世生物(688399)披露拟取消监事会并修订公司章程,10月29日股价下跌1.49%
证券之星 · 10-29
硕世生物(688399)披露拟取消监事会并修订公司章程,10月29日股价下跌1.49%
硕世生物(688399)披露2025年第三季度报告,10月27日股价上涨1.88%
证券之星 · 10-27
硕世生物(688399)披露2025年第三季度报告,10月27日股价上涨1.88%
硕世生物(688399)2025年三季报简析:净利润同比下降88.38%
证券之星 · 10-26
硕世生物(688399)2025年三季报简析:净利润同比下降88.38%
每周股票复盘:硕世生物(688399)Q3净利同比降88.38%
证券之星 · 10-26
每周股票复盘:硕世生物(688399)Q3净利同比降88.38%
硕世生物最新公告:前三季度净利润315.17万元同比下降88.38%
证券之星 · 10-24
硕世生物最新公告:前三季度净利润315.17万元同比下降88.38%
股市必读:硕世生物(688399)股东户数0.76万户,较上期减少0.94%
证券之星 · 10-24
股市必读:硕世生物(688399)股东户数0.76万户,较上期减少0.94%
每周股票复盘:硕世生物(688399)股东户数减少3.85%,户均持股市值70.11万元
证券之星 · 10-19
每周股票复盘:硕世生物(688399)股东户数减少3.85%,户均持股市值70.11万元
硕世生物(688399)9月30日股东户数0.77万户,较上期减少3.85%
证券之星 · 10-13
硕世生物(688399)9月30日股东户数0.77万户,较上期减少3.85%
10月9日硕世生物涨7.34%,鑫元专精特新混合A基金重仓该股
证券之星 · 10-09
10月9日硕世生物涨7.34%,鑫元专精特新混合A基金重仓该股
硕世生物(688399.SH)取得两项医疗器械注册证
智通财经 · 09-29
硕世生物(688399.SH)取得两项医疗器械注册证
每周股票复盘:硕世生物(688399)股东户数减少4.82%,户均持股上升
证券之星 · 09-28
每周股票复盘:硕世生物(688399)股东户数减少4.82%,户均持股上升
硕世生物(688399)9月19日股东户数0.8万户,较上期减少4.82%
证券之星 · 09-24
硕世生物(688399)9月19日股东户数0.8万户,较上期减少4.82%
硕世生物副总经理刘中华突发疾病去世 终年56岁
格隆汇 · 09-12
硕世生物副总经理刘中华突发疾病去世 终年56岁
加载更多
公司概况
公司名称:
江苏硕世生物科技股份有限公司
所属行业:
医药制造业
上市日期:
2019-12-05
主营业务:
江苏硕世生物科技股份有限公司的主营业务是体外诊断试剂、配套检测仪器等体外诊断产品的研发、生产和销售。公司的主要产品是体外诊断试剂、配套检测仪器。截至报告期末,公司已取得国内尚在有效期内的医疗器械注册证/备案凭证154项,其中Ⅲ类医疗器械注册证32项,Ⅱ类医疗器械注册证28项;在海外获得的尚在有效期内注册和备案产品共计542项;已取得国内授权专利108项,其中发明专利51项,实用新型专利53项,外观设计专利4项;软件著作权27项。
发行价格:
46.78
{"stockData":{"symbol":"688399","market":"SH","secType":"STK","nameCN":"硕世生物","latestPrice":66.41,"timestamp":1765954801000,"preClose":66.86,"halted":0,"volume":897201,"delay":0,"changeRate":-0.0067,"floatShares":83871700,"shares":83871700,"eps":-0.3096,"marketStatus":"已收盘","change":-0.45,"latestTime":"12-17 15:00:01","open":67.15,"high":68,"low":65.52,"amount":59628500,"amplitude":0.0371,"askPrice":66.44,"askSize":2,"bidPrice":66.41,"bidSize":34,"shortable":0,"etf":0,"ttmEps":-0.3096,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1766021400000},"marketStatusCode":5,"adr":0,"adjPreClose":66.86,"symbolType":"stock_kcb","openAndCloseTimeList":[[1765935000000,1765942200000],[1765947600000,1765954800000]],"highLimit":73.55,"lowLimit":60.17,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":83871721,"isCdr":false,"pbRate":1.88,"roa":"--","roe":"0.1%","epsLYR":-0.03,"committee":-0.265625,"marketValue":5570000000,"turnoverRate":0.0107,"status":1,"afterMarket":{"amount":0,"volume":0,"close":66.41,"buyVolume":0,"sellVolume":0,"time":1765956837768,"indexStatus":"已收盘 12-17 15:30:00","preClose":66.86},"floatMarketCap":5570000000},"requestUrl":"/m/hq/s/688399","defaultTab":"news","newsList":[{"id":"2589876710","title":"硕世生物最新公告:公司猴痘病毒核酸检测试剂盒被列入WHO应急使用清单","url":"https://stock-news.laohu8.com/highlight/detail?id=2589876710","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589876710?lang=zh_cn&edition=full","pubTime":"2025-12-07 15:40","pubTimestamp":1765093233,"startTime":"0","endTime":"0","summary":"硕世生物(688399.SH)公告称,公司产品猴痘病毒核酸检测试剂盒(荧光PCR法)于近日被列入世界卫生组织(WHO)应急使用清单。该产品批准日期为2025年12月3日,采购期限为1年。公司表示,被列入WHO EUL可为WHO成员国和各意向采购方提供采购依据,对公司产品在相关海外市场的推广和销售起到推动作用。但实际销售情况受海外市场政策环境、检测需求、同类产品竞争等因素影响,产品销售规模存在不确定性。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120700002594.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688399","BK0239"],"gpt_icon":0},{"id":"2589813852","title":"硕世生物(688399)披露实际控制人续签一致行动协议,12月05日股价下跌0.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2589813852","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589813852?lang=zh_cn&edition=full","pubTime":"2025-12-05 22:23","pubTimestamp":1764944605,"startTime":"0","endTime":"0","summary":"截至2025年12月5日收盘,硕世生物报收于67.98元,较前一交易日下跌0.77%,最新总市值为57.02亿元。该股当日开盘68.94元,最高68.94元,最低67.1元,成交额达5547.08万元,换手率为0.98%。公司近日发布公告称,实际控制人房永生、梁锡林、王国强于2025年12月5日续签《一致行动协议》,协议自签署日起生效,有效期十二个月。本次续签旨在保持公司经营的连续性与稳定性,确保决策一致性。续签后公司实际控制权未发生变化,不存在损害中小投资者利益的情形。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120500040463.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688399","BK0239"],"gpt_icon":0},{"id":"2588014624","title":"硕世生物(688399)11月20日股东户数0.77万户,较上期增加2.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588014624","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588014624?lang=zh_cn&edition=full","pubTime":"2025-12-03 17:28","pubTimestamp":1764754128,"startTime":"0","endTime":"0","summary":"证券之星消息,近日硕世生物披露,截至2025年11月20日公司股东户数为7710.0户,较11月10日增加198.0户,增幅为2.64%。在医疗器械行业个股中,硕世生物股东户数低于行业平均水平,截至11月20日,医疗器械行业平均股东户数为2.2万户。从股价来看,2025年11月10日至2025年11月20日,硕世生物区间跌幅为17.86%,在此期间股东户数增加198.0户,增幅为2.64%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120300027184.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688399","BK0239"],"gpt_icon":0},{"id":"2584532359","title":"硕世生物:截至2025年11月10日,公司股东总数7512户","url":"https://stock-news.laohu8.com/highlight/detail?id=2584532359","media":"证券日报 ","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584532359?lang=zh_cn&edition=full","pubTime":"2025-11-18 21:39","pubTimestamp":1763473140,"startTime":"0","endTime":"0","summary":"证券日报网讯硕世生物11月18日在互动平台回答投资者提问时表示,截至2025年11月10日,公司股东总数7,512户。(文章来源:证券日报)\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-11-18/doc-infxvtuy2606631.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-11-18/doc-infxvtuy2606631.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","688399"],"gpt_icon":0},{"id":"2583651614","title":"每周股票复盘:硕世生物(688399)召开2025年第二次临时股东大会并通过多项治理议案","url":"https://stock-news.laohu8.com/highlight/detail?id=2583651614","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583651614?lang=zh_cn&edition=full","pubTime":"2025-11-16 03:31","pubTimestamp":1763235072,"startTime":"0","endTime":"0","summary":"本周关注点来自公司公告汇总:硕世生物2025年第二次临时股东大会审议通过变更注册资本、取消监事会并修订公司章程等议案。江苏硕世生物科技股份有限公司于2025年11月11日召开2025年第二次临时股东大会,会议由董事会召集,董事长王国强主持,采用现场与网络投票结合方式召开。江苏硕世生物科技股份有限公司于2025年11月11日召开职工代表大会,选举贾兆强先生为公司职工董事,任期自审议通过之日起至第三届董事会任期届满。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111600000853.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688399"],"gpt_icon":0},{"id":"2582362022","title":"硕世生物(688399)披露2025年第二次临时股东大会决议公告,11月11日股价下跌1.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582362022","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582362022?lang=zh_cn&edition=full","pubTime":"2025-11-11 22:23","pubTimestamp":1762871005,"startTime":"0","endTime":"0","summary":"截至2025年11月11日收盘,硕世生物报收于76.14元,较前一交易日下跌1.65%,最新总市值为63.86亿元。近日,江苏硕世生物科技股份有限公司发布2025年第二次临时股东大会决议公告。公告显示,公司于2025年11月11日召开2025年第二次临时股东大会,会议由董事会召集,董事长王国强主持,采用现场与网络投票结合方式召开。出席会议股东共63人,代表有表决权股份总数34,754,254股,占公司总股本的41.4373%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111100040871.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688399","BK0239"],"gpt_icon":0},{"id":"2580708474","title":"每周股票复盘:硕世生物(688399)拟取消监事会并调整注册资本","url":"https://stock-news.laohu8.com/highlight/detail?id=2580708474","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580708474?lang=zh_cn&edition=full","pubTime":"2025-11-02 06:15","pubTimestamp":1762035321,"startTime":"0","endTime":"0","summary":"截至2025年10月31日收盘,硕世生物报收于77.09元,较上周的77.3元下跌0.27%。本周,硕世生物10月28日盘中最高价报80.3元。本周关注点公司公告汇总:硕世生物拟取消监事会,由董事会下设审计委员会行使监事会职权。公司公告汇总江苏硕世生物科技股份有限公司召开2025年第二次临时股东大会,审议变更注册资本、取消监事会并修订《公司章程》及制定修订部分治理制度的议案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110200001287.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688399"],"gpt_icon":0},{"id":"2579973111","title":"硕世生物(688399)披露拟取消监事会并修订公司章程,10月29日股价下跌1.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579973111","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579973111?lang=zh_cn&edition=full","pubTime":"2025-10-29 17:51","pubTimestamp":1761731511,"startTime":"0","endTime":"0","summary":"截至2025年10月29日收盘,硕世生物报收于77.28元,较前一交易日下跌1.49%,最新总市值为64.82亿元。近日,江苏硕世生物科技股份有限公司发布2025年第二次临时股东大会会议材料,公告公司拟变更注册资本、取消监事会并修订《公司章程》及相关治理制度。因股份回购注销,公司总股本由5862万股变更为5667.0082万股,注册资本相应减少;随后以资本公积每1股转增0.48股,总股本增至8387.1721万股,注册资本变更为8387.1721万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900037603.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688399","BK0239"],"gpt_icon":0},{"id":"2578647614","title":"硕世生物(688399)披露2025年第三季度报告,10月27日股价上涨1.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578647614","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578647614?lang=zh_cn&edition=full","pubTime":"2025-10-27 17:57","pubTimestamp":1761559058,"startTime":"0","endTime":"0","summary":"截至2025年10月27日收盘,硕世生物报收于78.75元,较前一交易日上涨1.88%,最新总市值为66.05亿元。该股当日开盘77.62元,最高79.57元,最低76.84元,成交额达1.9亿元,换手率为2.87%。近日,江苏硕世生物科技股份有限公司发布《2025年第三季度报告》。公告显示,年初至报告期末,公司实现营业收入257,507,844.76元,较上年同期下降3.95%;归属于上市公司股东的净利润为3,151,662.14元,同比下降88.38%。同期,经营活动产生的现金流量净额为19,424,952.97元,同比下降79.90%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102700027524.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688399","BK0239"],"gpt_icon":0},{"id":"2578168367","title":"硕世生物(688399)2025年三季报简析:净利润同比下降88.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578168367","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578168367?lang=zh_cn&edition=full","pubTime":"2025-10-26 06:06","pubTimestamp":1761430014,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期硕世生物发布2025年三季报。根据财报显示,硕世生物净利润同比下降88.38%。截至本报告期末,公司营业总收入2.58亿元,同比下降3.95%,归母净利润315.17万元,同比下降88.38%。按单季度数据看,第三季度营业总收入8192.73万元,同比下降9.61%,第三季度归母净利润-84.1万元,同比上升60.44%。本次财报公布的各项数据指标表现不尽如人意。),公司上市来已有年报5份,亏损年份2次,显示生意模式比较脆弱。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102600001707.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688399"],"gpt_icon":0},{"id":"2578502894","title":"每周股票复盘:硕世生物(688399)Q3净利同比降88.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578502894","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578502894?lang=zh_cn&edition=full","pubTime":"2025-10-26 02:55","pubTimestamp":1761418511,"startTime":"0","endTime":"0","summary":"截至2025年10月24日收盘,硕世生物报收于77.3元,较上周的68.5元上涨12.85%。本周,硕世生物10月24日盘中最高价报79.57元。本周关注点来自业绩披露要点:2025年前三季度归属于上市公司股东的净利润为315.17万元,同比下降88.38%。股本股东变化截至2025年10月20日,硕世生物股东户数为7620户,较9月30日减少72户,减幅0.94%。经营活动产生的现金流量净额为1942.50万元,同比下降79.90%。基本每股收益为0.04元,同比下降87.10%。注册资本由5862万元变更为8387.1721万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102600000605.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688399"],"gpt_icon":0},{"id":"2577512200","title":"硕世生物最新公告:前三季度净利润315.17万元同比下降88.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577512200","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577512200?lang=zh_cn&edition=full","pubTime":"2025-10-24 22:00","pubTimestamp":1761314402,"startTime":"0","endTime":"0","summary":"硕世生物(688399.SH)公告称,2025年前三季度公司实现营业收入2.58亿元,同比下降3.95%;归属于上市公司股东的净利润315.17万元,同比下降88.38%。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102400042040.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688399"],"gpt_icon":0},{"id":"2577963535","title":"股市必读:硕世生物(688399)股东户数0.76万户,较上期减少0.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577963535","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577963535?lang=zh_cn&edition=full","pubTime":"2025-10-24 04:02","pubTimestamp":1761249737,"startTime":"0","endTime":"0","summary":"截至2025年10月23日收盘,硕世生物报收于75.38元,上涨7.07%,换手率4.49%,成交量3.77万手,成交额2.73亿元。交易信息汇总资金流向10月23日主力资金净流出443.13万元,占总成交额1.62%;游资资金净流入582.1万元,占总成交额2.13%;散户资金净流出138.97万元,占总成交额0.51%。股本股东变化股东户数变动截至2025年10月20日,硕世生物股东户数为7620户,较9月30日减少72户,减幅0.94%。户均持股数量由上期的1.09万股上升至1.1万股,户均持股市值为77.72万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102400003946.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688399"],"gpt_icon":0},{"id":"2576735041","title":"每周股票复盘:硕世生物(688399)股东户数减少3.85%,户均持股市值70.11万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2576735041","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576735041?lang=zh_cn&edition=full","pubTime":"2025-10-19 04:47","pubTimestamp":1760820426,"startTime":"0","endTime":"0","summary":"截至2025年10月17日收盘,硕世生物报收于68.5元,较上周的68.1元上涨0.59%。本周,硕世生物10月16日盘中最高价报71.8元。本周关注点股本股东变化:截至2025年9月30日股东户数为7692.0户,较9月19日减少3.85%股本股东变化:户均持股数量由1.05万股增至1.09万股,户均持股市值为70.11万元股本股东变化股东户数变动截至2025年9月30日,硕世生物股东户数为7692.0户,较9月19日减少308.0户,减幅为3.85%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101900001010.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688399"],"gpt_icon":0},{"id":"2575447987","title":"硕世生物(688399)9月30日股东户数0.77万户,较上期减少3.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2575447987","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575447987?lang=zh_cn&edition=full","pubTime":"2025-10-13 17:05","pubTimestamp":1760346305,"startTime":"0","endTime":"0","summary":"证券之星消息,近日硕世生物披露,截至2025年9月30日公司股东户数为7692.0户,较9月19日减少308.0户,减幅为3.85%。在医疗器械行业个股中,硕世生物股东户数低于行业平均水平,截至9月30日,医疗器械行业平均股东户数为2.15万户。从股价来看,2025年9月19日至2025年9月30日,硕世生物区间跌幅为4.87%,在此期间股东户数减少308.0户,减幅为3.85%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101300018822.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688399","BK0239"],"gpt_icon":0},{"id":"2574093131","title":"10月9日硕世生物涨7.34%,鑫元专精特新混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2574093131","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574093131?lang=zh_cn&edition=full","pubTime":"2025-10-09 16:38","pubTimestamp":1759999115,"startTime":"0","endTime":"0","summary":"证券之星消息,10月9日硕世生物涨7.34%,收盘报69.02元,换手率3.57%,成交量2.99万手,成交额2.03亿元。重仓硕世生物的公募基金请见下表:根据2025基金半年报公募基金重仓股数据,重仓该股的公募基金共1家,其中持有数量最多的公募基金为鑫元基金的鑫元专精特新混合A。该公募基金现任基金经理为陆杨。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025100900020817.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688399","399267","BK0239"],"gpt_icon":0},{"id":"2571385620","title":"硕世生物(688399.SH)取得两项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2571385620","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2571385620?lang=zh_cn&edition=full","pubTime":"2025-09-29 17:13","pubTimestamp":1759137201,"startTime":"0","endTime":"0","summary":"智通财经APP讯,硕世生物(688399.SH)发布公告,公司近日收到国家药品监督管理局签发的医疗器械注册证(体外诊断试剂),产品名称:腺病毒抗原检测试剂盒(胶体金法)、七项呼吸道病原体核酸检测试剂盒(荧光PCR法)。上述《医疗器械注册证》的取得,丰富了公司产品种类,扩充了公司在体外诊断领域的布局,不断满足多元化的临床需求,将增强公司综合竞争力,有利于进一步提高公司的市场拓展能力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1350635.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159883","BK1583","BK0239","BK1100","09997","BK1574","BK1222","09996","688399"],"gpt_icon":0},{"id":"2570894822","title":"每周股票复盘:硕世生物(688399)股东户数减少4.82%,户均持股上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2570894822","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570894822?lang=zh_cn&edition=full","pubTime":"2025-09-28 03:34","pubTimestamp":1759001655,"startTime":"0","endTime":"0","summary":"截至2025年9月26日收盘,硕世生物报收于63.34元,较上周的67.59元下跌6.29%。本周,硕世生物9月22日盘中最高价报67.71元。硕世生物当前最新总市值53.12亿元,在医疗器械板块市值排名67/126,在两市A股市值排名3096/5157。本周关注点股本股东变化:截至2025年9月19日股东户数为8000.0户,较前期减少4.82%股本股东变化:户均持股数量增至1.05万股,户均持股市值达70.86万元股本股东变化股东户数变动截至2025年9月19日,硕世生物股东户数为8000.0户,较7月31日减少405.0户,减幅4.82%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092800000830.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688399"],"gpt_icon":0},{"id":"2569774903","title":"硕世生物(688399)9月19日股东户数0.8万户,较上期减少4.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2569774903","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569774903?lang=zh_cn&edition=full","pubTime":"2025-09-24 17:19","pubTimestamp":1758705561,"startTime":"0","endTime":"0","summary":"证券之星消息,近日硕世生物披露,截至2025年9月19日公司股东户数为8000.0户,较7月31日减少405.0户,减幅为4.82%。在医疗器械行业个股中,硕世生物股东户数低于行业平均水平,截至9月19日,医疗器械行业平均股东户数为2.16万户。从股价来看,2025年7月31日至2025年9月19日,硕世生物区间涨幅为23.91%,在此期间股东户数减少405.0户,减幅为4.82%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092400029935.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688399","BK0239"],"gpt_icon":0},{"id":"2566197354","title":"硕世生物副总经理刘中华突发疾病去世 终年56岁","url":"https://stock-news.laohu8.com/highlight/detail?id=2566197354","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566197354?lang=zh_cn&edition=full","pubTime":"2025-09-12 18:36","pubTimestamp":1757673390,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0239","688399"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1765961125683,"stockEarnings":[{"period":"1week","weight":0.003},{"period":"1month","weight":-0.1095},{"period":"3month","weight":-0.0446},{"period":"6month","weight":0.5371},{"period":"1year","weight":0.4585},{"period":"ytd","weight":0.5885}],"compareEarnings":[{"period":"1week","weight":-0.0217},{"period":"1month","weight":-0.0415},{"period":"3month","weight":-0.0133},{"period":"6month","weight":0.1376},{"period":"1year","weight":0.1295},{"period":"ytd","weight":0.1411}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"江苏硕世生物科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"7418人(较上一季度减少0.39%)","perCapita":"11306股","listingDate":"2019-12-05","address":"江苏省泰州市海陵区药城大道837号","registeredCapital":"8387万元","survey":" 江苏硕世生物科技股份有限公司的主营业务是体外诊断试剂、配套检测仪器等体外诊断产品的研发、生产和销售。公司的主要产品是体外诊断试剂、配套检测仪器。截至报告期末,公司已取得国内尚在有效期内的医疗器械注册证/备案凭证154项,其中Ⅲ类医疗器械注册证32项,Ⅱ类医疗器械注册证28项;在海外获得的尚在有效期内注册和备案产品共计542项;已取得国内授权专利108项,其中发明专利51项,实用新型专利53项,外观设计专利4项;软件著作权27项。","listedPrice":46.78},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"硕世生物(688399)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供硕世生物(688399)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"硕世生物,688399,硕世生物股票,硕世生物股票老虎,硕世生物股票老虎国际,硕世生物行情,硕世生物股票行情,硕世生物股价,硕世生物股市,硕世生物股票价格,硕世生物股票交易,硕世生物股票购买,硕世生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"硕世生物(688399)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供硕世生物(688399)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}